| scholarly article | Q13442814 |
| P50 | author | Ralf Bartenschlager | Q20664754 |
| Thomas Pietschmann | Q42605515 | ||
| George Koutsoudakis | Q89146238 | ||
| Stephanie Kallis | Q117234810 | ||
| P2093 | author name string | Eva Herrmann | |
| P2860 | cites work | Binding of hepatitis C virus to CD81 | Q22004178 |
| Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection | Q24546318 | ||
| Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I | Q24556673 | ||
| Robust hepatitis C virus infection in vitro | Q27470013 | ||
| Efficient hepatitis C virus cell culture system: what a difference the host cell makes | Q27470192 | ||
| Dissecting the interferon-induced inhibition of hepatitis C virus replication by using a novel host cell line | Q27472675 | ||
| Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication | Q27472912 | ||
| Time- and Temperature-Dependent Activation of Hepatitis C Virus for Low-pH-Triggered Entry | Q27472926 | ||
| Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells | Q27473106 | ||
| Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras | Q27473179 | ||
| Characterization of the Early Steps of Hepatitis C Virus Infection by Using Luciferase Reporter Viruses | Q27473226 | ||
| Hepatitis C Virus Entry Depends on Clathrin-Mediated Endocytosis | Q27473290 | ||
| Viral and Cellular Determinants of Hepatitis C Virus RNA Replication in Cell Culture | Q27473345 | ||
| Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro | Q27473436 | ||
| Replication of Hepatitis C Virus (HCV) RNA in Mouse Embryonic Fibroblasts: Protein Kinase R (PKR)-Dependent and PKR-Independent Mechanisms for Controlling HCV RNA Replication and Mediating Interferon Activities | Q27477459 | ||
| Replication of Hepatitis C Virus Subgenomes in Nonhepatic Epithelial and Mouse Hepatoma Cells | Q27478415 | ||
| The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses | Q27860685 | ||
| Production of infectious hepatitis C virus in tissue culture from a cloned viral genome | Q27860899 | ||
| Complete replication of hepatitis C virus in cell culture | Q27860934 | ||
| Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes | Q27861119 | ||
| A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications | Q28213193 | ||
| CD81 is an entry coreceptor for hepatitis C virus | Q29614812 | ||
| CD81 is required for hepatitis C virus glycoprotein-mediated viral infection | Q29619745 | ||
| Course and outcome of hepatitis C | Q29620057 | ||
| Natural history of chronic hepatitis C | Q29620673 | ||
| Novel insights into hepatitis C virus replication and persistence | Q29620681 | ||
| Kissing-loop interaction in the 3' end of the hepatitis C virus genome essential for RNA replication | Q30014846 | ||
| Cell entry of hepatitis C virus | Q36385222 | ||
| Hepatitis C virus entry: potential receptors and their biological functions | Q36444205 | ||
| Alternative approaches for efficient inhibition of hepatitis C virus RNA replication by small interfering RNAs | Q37010585 | ||
| Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate | Q38352468 | ||
| Hepatitis C virus subgenomic replicons in the human embryonic kidney 293 cell line | Q40377218 | ||
| A transient three-plasmid expression system for the production of high titer retroviral vectors | Q40393091 | ||
| Genotype 2a hepatitis C virus subgenomic replicon can replicate in HepG2 and IMY-N9 cells | Q40584675 | ||
| Electrotransfection with "intracellular" buffer. | Q41387908 | ||
| Binding of hepatitis C virus envelope protein E2 to CD81 up-regulates matrix metalloproteinase-2 in human hepatic stellate cells. | Q42820160 | ||
| Use of VSV-G pseudotyped retroviral vectors to target murine osteoprogenitor cells | Q45877033 | ||
| P4510 | describes a project that uses | Huh-7-Lunet | Q54896854 |
| Huh-7.5 | Q54896856 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | virus | Q808 |
| virology | Q7215 | ||
| hepatitis C | Q154869 | ||
| Hepatitis C virus | Q708693 | ||
| cell line | Q21014462 | ||
| P304 | page(s) | 588-98 | |
| P577 | publication date | 2007-01-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | The Level of CD81 Cell Surface Expression Is a Key Determinant for Productive Entry of Hepatitis C Virus into Host Cells | |
| P478 | volume | 81 |
| Q40278524 | A Novel Inhibitor IDPP Interferes with Entry and Egress of HCV by Targeting Glycoprotein E1 in a Genotype-Specific Manner |
| Q28475468 | A Novel Small Molecule Inhibitor of Hepatitis C Virus Entry |
| Q33981285 | A concerted action of hepatitis C virus p7 and nonstructural protein 2 regulates core localization at the endoplasmic reticulum and virus assembly |
| Q28488372 | A novel monoclonal anti-CD81 antibody produced by genetic immunization efficiently inhibits Hepatitis C virus cell-cell transmission |
| Q39793262 | A single point mutation in E2 enhances hepatitis C virus infectivity and alters lipoprotein association of viral particles. |
| Q34534451 | A subclone of HuH-7 with enhanced intracellular hepatitis C virus production and evasion of virus related-cell cycle arrest |
| Q27314827 | ABHD5/CGI-58, the Chanarin-Dorfman Syndrome Protein, Mobilises Lipid Stores for Hepatitis C Virus Production |
| Q34563532 | Active RNA replication of hepatitis C virus downregulates CD81 expression |
| Q35103718 | Activity and the metabolic activation pathway of the potent and selective hepatitis C virus pronucleotide inhibitor PSI-353661. |
| Q33628805 | Adaptation of hepatitis C virus to mouse CD81 permits infection of mouse cells in the absence of human entry factors. |
| Q38723923 | An Optimized Hepatitis C Virus E2 Glycoprotein Core Adopts a Functional Homodimer That Efficiently Blocks Virus Entry |
| Q39440504 | An adaptive mutation in NS2 is essential for efficient production of infectious 1b/2a chimeric hepatitis C virus in cell culture |
| Q27480348 | Analysis of Hepatitis C Virus Superinfection Exclusion by Using Novel Fluorochrome Gene-Tagged Viral Genomes |
| Q28534716 | Antiviral activity of glycyrrhizin against hepatitis C virus in vitro |
| Q43038816 | Antiviral effects of amantadine and iminosugar derivatives against hepatitis C virus |
| Q24301976 | Apolipoprotein E likely contributes to a maturation step of infectious hepatitis C virus particles and interacts with viral envelope glycoproteins |
| Q33913588 | Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein |
| Q64082020 | Building a mechanistic mathematical model of hepatitis C virus entry |
| Q27486789 | CD81 Is a Central Regulator of Cellular Events Required for Hepatitis C Virus Infection of Human Hepatocytes |
| Q54231580 | CD81 Receptor Regions outside the Large Extracellular Loop Determine Hepatitis C Virus Entry into Hepatoma Cells. |
| Q37611819 | CD81 and hepatitis C virus (HCV) infection. |
| Q28114859 | CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells |
| Q37611842 | CD81-receptor associations--impact for hepatitis C virus entry and antiviral therapies. |
| Q27485033 | Cell Culture Adaptation of Hepatitis C Virus and In Vivo Viability of an Adapted Variant |
| Q39683340 | Cell culture and in vivo analyses of cytopathic hepatitis C virus mutants |
| Q28476674 | Cell culture replication of a genotype 1b hepatitis C virus isolate cloned from a patient who underwent liver transplantation |
| Q36353469 | Cell culture-derived HCV cannot infect synovial fibroblasts |
| Q27487385 | Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells |
| Q37514366 | Cellular and molecular biology of HCV infection and hepatitis |
| Q59351863 | Characterization of a Threonine-Rich Cluster in Hepatitis C Virus Nonstructural Protein 5A and Its Contribution to Hyperphosphorylation |
| Q35602284 | Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibody |
| Q27488834 | Combined antiviral activity of interferon-α and RNA interference directed against hepatitis C without affecting vector delivery and gene silencing |
| Q39955792 | Contribution of redox status to hepatitis C virus E2 envelope protein function and antigenicity |
| Q27486112 | Critical Role of Virion-Associated Cholesterol and Sphingolipid in Hepatitis C Virus Infection |
| Q37201846 | Cutting the gordian knot-development and biological relevance of hepatitis C virus cell culture systems |
| Q47555918 | Determinants in the IgV Domain of human HAVCR1 (TIM-1) are required to enhance Hepatitis C Virus Entry. |
| Q40065076 | Development of plaque assays for hepatitis C virus-JFH1 strain and isolation of mutants with enhanced cytopathogenicity and replication capacity |
| Q39131897 | Different responses of two highly permissive cell lines upon HCV infection |
| Q27485293 | Effect of Cell Polarization on Hepatitis C Virus Entry |
| Q42978768 | Efficient replication of primary or culture hepatitis C virus isolates in human liver slices: a relevant ex vivo model of liver infection |
| Q27486405 | Efficient trans-Encapsidation of Hepatitis C Virus RNAs into Infectious Virus-Like Particles |
| Q38703848 | Entry and release of hepatitis C virus in polarized human hepatocytes |
| Q38046287 | Entry and replication of recombinant hepatitis C viruses in cell culture |
| Q24336433 | Entry of pseudotyped hepatitis C virus into primary human hepatocytes depends on the scavenger class B type I receptor |
| Q41979690 | Ephrin-B2 expression critically influences Nipah virus infection independent of its cytoplasmic tail |
| Q27485487 | Essential Role of Domain III of Nonstructural Protein 5A for Hepatitis C Virus Infectious Particle Assembly |
| Q45354663 | Expression of CD81, SR-BI and LDLR in lymphocytes and monocytes from patients with classic and occult hepatitis C virus infection. |
| Q33579851 | Functional selection of hepatitis C virus envelope E2-binding Peptide ligands by using ribosome display |
| Q92441611 | Gene Expression Profiling of Different Huh7 Variants Reveals Novel Hepatitis C Virus Host Factors |
| Q39470525 | Generation and quantitation of infectious hepatitis C virus derived from cell culture (HCVcc). |
| Q39376758 | Genotype and subtype profiling of PSI-7977 as a nucleotide inhibitor of hepatitis C virus |
| Q57564402 | HCV Receptors and Virus Entry |
| Q27468911 | HCV derived from sera of HCV-infected patients induces pro-fibrotic effects in human primary fibroblasts by activating GLI2 |
| Q27489071 | Hepatitis C Virus Infection in Phenotypically Distinct Huh7 Cell Lines |
| Q27489242 | Hepatitis C Virus entry: the early steps in the viral replication cycle |
| Q27480902 | Hepatitis C Virus p7 Protein Is Crucial for Assembly and Release of Infectious Virions |
| Q59350550 | Hepatitis C virus and the kidney |
| Q57295205 | Hepatitis C virus cell culture models: an encomium on basic research paving the road to therapy development |
| Q56360968 | Hepatitis C virus enters liver cells using the CD81 receptor complex proteins calpain-5 and CBLB |
| Q36946317 | Hepatitis C virus entry |
| Q56911131 | Hepatitis C virus entry into the hepatocyte |
| Q34016463 | Hepatitis C virus entry: molecular mechanisms and targets for antiviral therapy |
| Q34235286 | Hepatitis C virus experimental model systems and antiviral drug research |
| Q96354472 | Hepatitis C virus exploits cyclophilin A to evade PKR |
| Q39119590 | Hepatitis C virus infection propagates through interactions between Syndecan-1 and CD81 and impacts the hepatocyte glycocalyx. |
| Q34618241 | Hepatitis C virus molecular clones and their replication capacity in vivo and in cell culture |
| Q38961245 | Hepatitis C virus nucleotide inhibitors PSI-352938 and PSI-353661 exhibit a novel mechanism of resistance requiring multiple mutations within replicon RNA. |
| Q45326080 | Hepatitis C virus replication depends on endosomal cholesterol homeostasis |
| Q27488905 | Hepatitis C virus replicons: dinosaurs still in business? |
| Q36427976 | Hepatitis C virus-host interactions, replication, and viral assembly |
| Q45325599 | Hepatitis C virus-induced prion protein expression facilitates hepatitis C virus replication. |
| Q38003914 | Hepatitis C virus: a new class of virus associated with particles derived from very low-density lipoproteins |
| Q35790979 | Hepatitis C-like viruses are produced in cells from rabbit and hare DNA |
| Q27490466 | Hepatoma Cell Density Promotes Claudin-1 and Scavenger Receptor BI Expression and Hepatitis C Virus Internalization |
| Q37174994 | Host neutralizing responses and pathogenesis of hepatitis C virus infection. |
| Q34197528 | Human liver transplantation as a model to study hepatitis C virus pathogenesis |
| Q27480357 | Identification of Determinants Involved in Initiation of Hepatitis C Virus RNA Synthesis by Using Intergenotypic Replicase Chimeras |
| Q34875666 | Identification of HNRNPK as regulator of hepatitis C virus particle production |
| Q38966123 | Increased replicative fitness can lead to decreased drug sensitivity of hepatitis C virus |
| Q84315962 | Influences of cyclosporin A and non-immunosuppressive derivatives on cellular cyclophilins and viral nucleocapsid protein during human coronavirus 229E replication |
| Q35004972 | Inhibition of hepatitis C virus replicon RNA synthesis by PSI-352938, a cyclic phosphate prodrug of β-D-2'-deoxy-2'-α-fluoro-2'-β-C-methylguanosine |
| Q27488199 | Interaction of hepatitis C virus envelope glycoprotein E2 with the large extracellular loop of tupaia CD81 |
| Q27486571 | Intragenotypic JFH1 based recombinant hepatitis C virus produces high levels of infectious particles but causes increased cell death |
| Q35072828 | Isolation and characterization of highly replicable hepatitis C virus genotype 1a strain HCV-RMT |
| Q24338608 | Lipid droplet-binding protein TIP47 regulates hepatitis C Virus RNA replication through interaction with the viral NS5A protein |
| Q34062532 | Lipoprotein lipase inhibits hepatitis C virus (HCV) infection by blocking virus cell entry |
| Q35630492 | Longitudinal Sequence and Functional Evolution within Glycoprotein E2 in Hepatitis C Virus Genotype 3a Infection |
| Q28478310 | Mathematical model of viral kinetics in vitro estimates the number of E2-CD81 complexes necessary for hepatitis C virus entry |
| Q40994676 | Modeling Suggests a Mechanism of Synergy Between Hepatitis C Virus Entry Inhibitors and Drugs of Other Classes |
| Q27490526 | Mouse-Specific Residues of Claudin-1 Limit Hepatitis C Virus Genotype 2a Infection in a Human Hepatocyte Cell Line |
| Q37629584 | Mutations that alter use of hepatitis C virus cell entry factors mediate escape from neutralizing antibodies |
| Q39641797 | Neutralizing antibody-resistant hepatitis C virus cell-to-cell transmission |
| Q37539700 | New and experimental therapies for HCV. |
| Q37489533 | New therapeutic approaches to hepatitis C virus |
| Q36921336 | New therapeutic opportunities for hepatitis C based on small RNA. |
| Q27491131 | Novel Function of CD81 in Controlling Hepatitis C Virus Replication |
| Q39598862 | Novel mutations in a tissue culture-adapted hepatitis C virus strain improve infectious-virus stability and markedly enhance infection kinetics |
| Q38106964 | Overcoming hurdles in hepatitis C virus research: efficient production of infectious virus in cell culture |
| Q45383963 | PCSK9 impedes hepatitis C virus infection in vitro and modulates liver CD81 expression |
| Q35866290 | Permissiveness of human hepatoma cell lines for HCV infection |
| Q27488433 | Polarization Restricts Hepatitis C Virus Entry into HepG2 Hepatoma Cells |
| Q27488616 | Production of Infectious Genotype 1b Virus Particles in Cell Culture and Impairment by Replication Enhancing Mutations |
| Q38938490 | RACK1 controls IRES-mediated translation of viruses |
| Q36956517 | Recent advances in our understanding of receptor binding, viral fusion and cell entry of hepatitis C virus: new targets for the design of antiviral agents |
| Q36933791 | Recent contributions of in vitro models to our understanding of hepatitis C virus life cycle |
| Q24337128 | Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment |
| Q21090530 | Reliance of host cholesterol metabolic pathways for the life cycle of hepatitis C virus |
| Q31129723 | Replication vesicles are load- and choke-points in the hepatitis C virus lifecycle |
| Q39157496 | Response of hepatitis C virus to long-term passage in the presence of alpha interferon: multiple mutations and a common phenotype. |
| Q27490313 | Role of RNA Structures in Genome Terminal Sequences of the Hepatitis C Virus for Replication and Assembly |
| Q27490535 | Role of Scavenger Receptor Class B Type I in Hepatitis C Virus Entry: Kinetics and Molecular Determinants |
| Q39723381 | Role of annexin A2 in the production of infectious hepatitis C virus particles |
| Q26777338 | Roles of lipoprotein receptors in the entry of hepatitis C virus |
| Q39584985 | Selection of clinically relevant protease inhibitor-resistant viruses using the genotype 2a hepatitis C virus infection system |
| Q34166233 | Soluble serum CD81 is elevated in patients with chronic hepatitis C and correlates with alanine aminotransferase serum activity |
| Q27488261 | Structural and Functional Characterization of Nonstructural Protein 2 for Its Role in Hepatitis C Virus Assembly |
| Q27666400 | Structural and Functional Studies of Nonstructural Protein 2 of the Hepatitis C Virus Reveal Its Key Role as Organizer of Virion Assembly |
| Q24598370 | Structural basis of ligand interactions of the large extracellular domain of tetraspanin CD81 |
| Q38615654 | Targeting HCV entry for development of therapeutics |
| Q27485588 | The CD81 Partner EWI-2wint Inhibits Hepatitis C Virus Entry |
| Q27485895 | The Hepatitis C Virus Replicon Presents a Higher Barrier to Resistance to Nucleoside Analogs than to Nonnucleoside Polymerase or Protease Inhibitors |
| Q45324462 | The Rationale for a Preventative HCV Virus-Like Particle (VLP) Vaccine |
| Q27488727 | The association of CD81 with tetraspanin-enriched microdomains is not essential for Hepatitis C virus entry |
| Q40087031 | The exchangeable apolipoprotein ApoC-I promotes membrane fusion of hepatitis C virus. |
| Q38695199 | The expanding toolbox for hepatitis C virus research. |
| Q37609487 | The hepatitis C virus and its hepatic environment: a toxic but finely tuned partnership |
| Q38968729 | The lysine methyltransferase SMYD3 interacts with hepatitis C virus NS5A and is a negative regulator of viral particle production |
| Q59352328 | Toll Like Receptor-7 and -9 agonists improve Hepatitis C Virus replication and infectivity inhibition by plasmacytoid dendritic cells |
| Q40404561 | Tuning a cellular lipid kinase activity adapts hepatitis C virus to replication in cell culture. |
| Q37891074 | Turning hepatitis C into a real virus |
| Q33889967 | Visualization and analysis of hepatitis C virus structural proteins at lipid droplets by super-resolution microscopy. |
Search more.